Academy Webinar: The Role of the RDN to Optimize Short- and Long-term Use of Anti-Obesity Medication

This webinar does not provide CPE credit.

Recordings of this 3-part series will be available for free viewing at eatrightPRO.


The newer second-generation obesity medications are yielding weight losses beyond what has typically been achieved with lifestyle interventions alone, including assisting in the management or prevention of obesity-related diseases. These benefits are making the use of these medications extremely popular. For a variety of reasons, from rapid weight loss, medication side effects, loss of excess lean body mass, titration challenges, micronutrient deficiencies and more, there is a critical need for the integration of the RDN to optimize short- and long-term clinical outcomes with individuals taking a newer obesity medication. However, the role of the RDN and the nature of traditional lifestyle intervention is changing.


In the absence, at this early stage, of well researched, evidence-based clinical recommendations in this area, RDNs delivering obesity and diabetes care can share their clinical experience and expertise and help build consensus around the topics detailed above. In addition, RDNs working in this area can offer RDN colleagues practical information on patient selection, nutrition assessment and nutrition-focused physical exam, shared decision making, dosing and titration best practices, lifestyle components, and helping patients set realistic expectations.


Join obesity management expert Beth Czerwony, MS, RD, CSOWM, LD, and Mary Lou Perry, MS, RDN, CDCES, a diabetes and obesity expert, to discuss these topics and more on the second of this three-part webinar series. Beyond the clinical and behavioral aspects of use are the challenges of access to medications, comprehensive obesity care and stigma. Jeanne Blankenship, MS RDN, VP, Policy Initiatives and Advocacy at the Academy of Nutrition and Dietetics will address these topics and provide an update on the Academy's efforts in Washington, D.C.



About the Speakers

Mary Lou Perry, MS, RDN, CDCES

Spending the last 40 years educating, counseling, and walking alongside persons with diabetes and obesity, Mary Lou currently works in a collaborative diabetes and cardiovascular practice at University of Virginia Health where she is also involved in precepting dietetic interns, medical students and residents. She is a member of the Weight Management Dietetic Practice Group and Diabetes Dietetic Practice Group in which she has held leadership positions.


Beth Czerwony, MS, RD, CSOWM, LD

A Clinical Registered Dietitian with the Cleveland Clinic's Center for Human Nutrition, Beth earned her Master of Science in Nutrition degree from Case Western Reserve University. In 2019, she earned her Certification in Obesity and Weight Management and has served as a preceptor for dietetic interns. She is member of the Academy's Weight Management Dietetic Practice Group, American Society of Metabolic and Bariatric Surgery, and The Obesity Society.


Jeanne Blankenship, MS, RDN

Oversees the Academy's public policy strategy, Jeanne leads staff and volunteers in advocacy, promoting public health initiatives, and collaborating with legislators and policy leaders to promote health and reduce the burden of chronic disease through nutrition services and interventions. Key areas include nutrition policy and legislation, professional licensure, payment and reimbursement, Academy alliances and the Academy's political action committee (ANDPAC).


When:  May 15, 2024 from 12:00 PM to 01:30 PM (CT)
Associated with  DPG26 Weight Management (WM)
Event Image